JPY 128.0
(-0.78%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 5.2 Billion JPY | 17.02% |
2022 | 4.44 Billion JPY | 30.87% |
2021 | 3.39 Billion JPY | 15.04% |
2020 | 2.95 Billion JPY | 11.52% |
2019 | 2.64 Billion JPY | 15.96% |
2018 | 2.28 Billion JPY | 18.58% |
2017 | 1.92 Billion JPY | 9.76% |
2016 | 1.75 Billion JPY | -4.79% |
2015 | 1.84 Billion JPY | -7.9% |
2014 | 2 Billion JPY | 23.36% |
2013 | 1.62 Billion JPY | 57.34% |
2012 | 1.03 Billion JPY | 106.63% |
2011 | 499.01 Million JPY | 22.99% |
2010 | 405.73 Million JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 1.37 Billion JPY | -16.4% |
2023 Q3 | 1.13 Billion JPY | -7.94% |
2023 FY | 5.2 Billion JPY | 17.02% |
2023 Q1 | 1.19 Billion JPY | -5.66% |
2023 Q2 | 1.23 Billion JPY | 2.59% |
2023 Q4 | 1.64 Billion JPY | 44.86% |
2022 FY | 4.44 Billion JPY | 30.87% |
2022 Q4 | 1.27 Billion JPY | 29.34% |
2022 Q2 | 1.19 Billion JPY | 19.45% |
2022 Q1 | 998.95 Million JPY | -0.77% |
2022 Q3 | 982.97 Million JPY | -17.63% |
2021 Q2 | 814.51 Million JPY | 4.46% |
2021 FY | 3.39 Billion JPY | 15.04% |
2021 Q4 | 1 Billion JPY | 26.36% |
2021 Q3 | 796.7 Million JPY | -2.19% |
2021 Q1 | 779.73 Million JPY | -12.72% |
2020 FY | 2.95 Billion JPY | 11.52% |
2020 Q1 | 657.56 Million JPY | 1.66% |
2020 Q2 | 650.08 Million JPY | -1.14% |
2020 Q3 | 752.56 Million JPY | 15.76% |
2020 Q4 | 893.33 Million JPY | 18.71% |
2019 Q3 | 652.54 Million JPY | -2.85% |
2019 Q4 | 646.83 Million JPY | -0.88% |
2019 FY | 2.64 Billion JPY | 15.96% |
2019 Q1 | 677.28 Million JPY | 4.68% |
2019 Q2 | 671.69 Million JPY | -0.82% |
2018 Q3 | 516.06 Million JPY | -4.6% |
2018 FY | 2.28 Billion JPY | 18.58% |
2018 Q1 | 579.88 Million JPY | 9.13% |
2018 Q4 | 646.97 Million JPY | 25.37% |
2018 Q2 | 540.97 Million JPY | -6.71% |
2017 Q2 | 461.86 Million JPY | 8.48% |
2017 Q1 | 425.77 Million JPY | -22.69% |
2017 FY | 1.92 Billion JPY | 9.76% |
2017 Q4 | 531.36 Million JPY | 4.8% |
2017 Q3 | 507.02 Million JPY | 9.78% |
2016 FY | 1.75 Billion JPY | -4.79% |
2016 Q4 | 550.72 Million JPY | 23.06% |
2016 Q3 | 447.53 Million JPY | 25.57% |
2016 Q2 | 356.4 Million JPY | -10.93% |
2016 Q1 | 400.13 Million JPY | -14.75% |
2015 FY | 1.84 Billion JPY | -7.9% |
2015 Q1 | 520.33 Million JPY | 6.75% |
2015 Q3 | 401.66 Million JPY | -11.09% |
2015 Q2 | 451.77 Million JPY | -13.18% |
2015 Q4 | 469.38 Million JPY | 16.86% |
2014 Q3 | 509.05 Million JPY | -10.15% |
2014 FY | 2 Billion JPY | 23.36% |
2014 Q1 | 438.24 Million JPY | -15.67% |
2014 Q2 | 566.57 Million JPY | 29.28% |
2014 Q4 | 487.42 Million JPY | -4.25% |
2013 Q3 | 376.57 Million JPY | 5.42% |
2013 FY | 1.62 Billion JPY | 57.34% |
2013 Q1 | 368.89 Million JPY | 13.74% |
2013 Q2 | 357.19 Million JPY | -3.17% |
2013 Q4 | 519.71 Million JPY | 38.01% |
2012 Q4 | 324.31 Million JPY | 27.5% |
2012 Q2 | 226.69 Million JPY | 0.41% |
2012 Q1 | 225.75 Million JPY | 25968.82% |
2012 FY | 1.03 Billion JPY | 106.63% |
2012 Q3 | 254.36 Million JPY | 12.21% |
2011 Q2 | 64.61 Million JPY | -65.95% |
2011 Q4 | 866 Thousand JPY | -99.64% |
2011 Q1 | 189.78 Million JPY | 0.0% |
2011 FY | 499.01 Million JPY | 22.99% |
2011 Q3 | 243.75 Million JPY | 277.24% |
2010 FY | 405.73 Million JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
DVx Inc. | 3.96 Billion JPY | -31.273% |
Seikagaku Corporation | 16.44 Billion JPY | 68.357% |
Eiken Chemical Co., Ltd. | 13.34 Billion JPY | 61.014% |
Create Medic Co., Ltd. | 4.67 Billion JPY | -11.301% |
PHC Holdings Corporation | 149.66 Billion JPY | 96.523% |
Techno Medica Co., Ltd. | 3.26 Billion JPY | -59.478% |
Rion Co., Ltd. | 10.85 Billion JPY | 52.074% |
Nihon Kohden Corporation | 91.75 Billion JPY | 94.329% |
Fukuda Denshi Co., Ltd. | 47.94 Billion JPY | 89.146% |
Japan Lifeline Co., Ltd. | 19.34 Billion JPY | 73.095% |
Japan Medical Dynamic Marketing, INC. | 11.65 Billion JPY | 55.355% |
CYBERDYNE Inc. | 4.12 Billion JPY | -26.022% |